MIT Researchers Use AI to Design Next-Generation Therapeutic Drugs
MIT scientists, led by James J. Collins, are leveraging artificial intelligence to accelerate the discovery and design of new therapeutic drugs, particularly antibiotics for multidrug-resistant pathogens. Collaborative efforts at MIT and partner institutions have yielded promising new candidates and established pipelines for AI-driven drug development.